Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington’s disease

[1]  P. McColgan,et al.  Huntington's disease: a clinical review , 2018, European journal of neurology.

[2]  C. Colwell,et al.  Neurocardiovascular deficits in the Q175 mouse model of Huntington's disease , 2017, Physiological reports.

[3]  M. T. Pellecchia,et al.  Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations , 2017, Journal of Nuclear Cardiology.

[4]  R. Faull,et al.  Symptom heterogeneity in Huntington's disease correlates with neuronal degeneration in the cerebral cortex , 2016, Neurobiology of Disease.

[5]  A. Morton,et al.  Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington’s disease , 2016, Human molecular genetics.

[6]  S. Pappatà,et al.  Reduced cardiac 123I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson’s disease , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  R. Roos,et al.  Huntington's disease: a clinical review , 2010, Orphanet journal of rare diseases.

[8]  J. Marinus,et al.  Autonomic symptoms in patients and pre‐manifest mutation carriers of Huntington’s disease , 2010, European journal of neurology.

[9]  D. Le Guludec,et al.  Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  M. MacDonald,et al.  RESEARCH ARTICLE: Systematic Assessment of BDNF and Its Receptor Levels in Human Cortices Affected by Huntington's Disease , 2007, Brain pathology.

[11]  K. Hoyt,et al.  Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease , 2007, Neurobiology of Disease.

[12]  Å. Petersén,et al.  Hypothalamic–endocrine aspects in Huntington's disease , 2006, The European journal of neuroscience.

[13]  B. Peterlin,et al.  Early sympathetic hyperactivity in Huntington's disease , 2004, European journal of neurology.

[14]  Johan Marinus,et al.  Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT , 2004, Movement disorders : official journal of the Movement Disorder Society.

[15]  H. Przuntek,et al.  Autonomic nervous system function in Huntington's disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[16]  T. Nakata,et al.  Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  J. Romano,et al.  Sympathetic skin response and heart rate variability in patients with Huntington disease. , 1999, Archives of neurology.

[18]  J. G. van Dijk,et al.  Autonomic nervous function in Huntington's disease. , 1988, Archives of neurology.

[19]  Å. Petersén,et al.  Thermoregulatory disorders in Huntington disease. , 2018, Handbook of clinical neurology.

[20]  Eric H Kim,et al.  The Neuropathology of Huntington's Disease. , 2015, Current topics in behavioral neurosciences.

[21]  Eric H Kim,et al.  Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease. , 2014, Journal of Huntington's disease.

[22]  M. Shattock,et al.  Cardiac Dysautonomia in Huntington's Disease. , 2013, Journal of Huntington's disease.